They can influence neurotransmitters and release peptides that are directly related to appetite
Interest in glucagon-like peptide 1 receptor agonists (GLP-1s) continues to surge due to their effectiveness in reducing body weight and improving metabolic outcomes
Not just reduce them slightly
Heres what were actually seeing in dental practices across the Austin area, what the current evidence says, and most importantly what you can do right now to protect your teeth if youre on one of these medications
Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, et al
These antiapoptotic mechanisms constitute vulnerabilities and, consequently, targeting them with either BCL2 family inhibitors 24,25,34 or via suppression of cFLIP 26 kills senescent cells